清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Treatment Modalities and Outcomes in Brainstem Cavernous Malformations: A Large Multicenter Observational Cohort Study

医学 倾向得分匹配 危险系数 显微外科 海绵状畸形 回顾性队列研究 放射外科 队列 人口 外科 观察研究 脑出血 改良兰金量表 病变 内科学 置信区间 蛛网膜下腔出血 放射治疗 缺血性中风 环境卫生 缺血
作者
Junlin Lu,Zongze Li,Hao Deng,Guangchao Shi,Wei Wang,Chao You,Wei Zhu,Rui Tian
出处
期刊:Stroke [Lippincott Williams & Wilkins]
被引量:2
标识
DOI:10.1161/strokeaha.123.046203
摘要

BACKGROUND: Symptomatic brainstem cavernous malformations (BSCMs) pose a high risk of morbidity and mortality due to recurrent hemorrhage, warranting aggressive management. However, few studies have compared the effectiveness of different treatment modalities for BSCMs. We aimed to assess the association of treatment modalities with recurrent hemorrhage and neurological outcomes in patients with BSCM. METHODS: We conducted a retrospective cohort study using an observational registry database covering population of southwest and southeast China. Adult patients with BSCM were included and followed up between March 1, 2011, to March 31, 2023. We compared outcomes between microsurgery and stereotactic radiosurgery (SRS) in propensity score-matched case pairs, incorporating demographic, medical history, and lesion characteristics. The outcomes studied included recurrent hemorrhage and poor prognosis (defined as a Glasgow Outcome Scale score, <4). Absolute rate differences and hazard ratios (HRs) with 95% CIs were calculated using Cox models. RESULTS: Among 736 diagnosed patients with BSCM, 96 (48 matched pairs) were included after exclusions and propensity score matching (mean age, 43.1 [SD, 12.1] years; 50% women). During the median 5-year follow-up, no significant differences in recurrent hemorrhage (4.2% [microsurgery] versus 14.6% [SRS], HR, 3.90 [95% CI, 0.46–32.65]; P =0.21) and poor prognosis (12.5% [microsurgery] versus 8.3% [SRS], HR, 0.29 [95% CI, 0.08–1.08]; P =0.07) were observed between microsurgery and SRS recipients. Furthermore, either microsurgery or SRS correlated with fewer recurrent hemorrhage (HR, 0.09 [95% CI, 0.02–0.39]; P =0.001; HR, 0.21 [95% CI, 0.07–0.69]; P =0.01) compared with conservative treatment. CONCLUSIONS: In this study, both microsurgery and SRS were safe and effective for BSCM, demonstrated comparable outcomes in recurrent hemorrhage and poor prognosis. However, interpretation should be cautious due to the potential for residual confounding. REGISTRATION: URL: https://www.chictr.org.cn/ ; Unique identifier: ChiCTR2300070907.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
laber完成签到,获得积分0
刚刚
zxx完成签到 ,获得积分10
2秒前
开心完成签到 ,获得积分10
10秒前
虞无声完成签到,获得积分10
14秒前
16秒前
harden9159完成签到,获得积分10
19秒前
wbh发布了新的文献求助10
22秒前
追梦完成签到,获得积分10
23秒前
万能图书馆应助wbh采纳,获得10
31秒前
如意的馒头完成签到 ,获得积分10
38秒前
大力的紊完成签到,获得积分10
40秒前
完美世界应助科研通管家采纳,获得10
1分钟前
科研通AI2S应助科研通管家采纳,获得10
1分钟前
丘比特应助科研通管家采纳,获得10
1分钟前
Kevin完成签到,获得积分10
1分钟前
1分钟前
Xu完成签到,获得积分10
1分钟前
ceeray23发布了新的文献求助20
1分钟前
mike2012完成签到 ,获得积分10
1分钟前
lilaccalla完成签到 ,获得积分10
1分钟前
YifanWang完成签到,获得积分0
1分钟前
1分钟前
如意枫叶发布了新的文献求助10
1分钟前
空白完成签到 ,获得积分10
1分钟前
拼搏的败完成签到 ,获得积分10
1分钟前
1分钟前
ceeray23发布了新的文献求助20
1分钟前
安安完成签到 ,获得积分10
2分钟前
淡然以柳完成签到 ,获得积分10
2分钟前
赘婿应助QQQQQQQ采纳,获得30
2分钟前
2分钟前
如意枫叶发布了新的文献求助10
2分钟前
你说的完成签到 ,获得积分10
2分钟前
稳重紫蓝完成签到 ,获得积分10
2分钟前
无花果应助lucy_zi采纳,获得10
2分钟前
zenabia完成签到 ,获得积分10
2分钟前
丘比特应助Dave采纳,获得10
2分钟前
2分钟前
2分钟前
小蘑菇应助hongtao采纳,获得10
2分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990793
求助须知:如何正确求助?哪些是违规求助? 3532233
关于积分的说明 11256590
捐赠科研通 3271081
什么是DOI,文献DOI怎么找? 1805229
邀请新用户注册赠送积分活动 882302
科研通“疑难数据库(出版商)”最低求助积分说明 809234